Alnylam Pharmaceuticals
ALNY
#590
Rank
NZ$56.89 B
Marketcap
$439.55
Share price
-5.66%
Change (1 day)
75.28%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company